XML 58 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Intangible Assets (Schedule Of Company's Intangible Assets) (Details) (USD $)
9 Months Ended 12 Months Ended
Jul. 27, 2013
Oct. 27, 2012
Finite-Lived Intangible Assets    
Gross Carrying Value $ 502,290,000 [1] $ 546,710,000
Accumulated Amortization 439,258,000 [1] 437,445,000
Net Carrying Value 63,032,000 [1] 109,265,000
Weighted-Average Remaining Useful Life (in years) 0 years 7 months 13 days 1 year 1 month 28 days
Cost of Fully Amortized Intangible Assets 69,400,000  
Trade name
   
Finite-Lived Intangible Assets    
Gross Carrying Value 460,000 100,000
Accumulated Amortization 82,000 97,000
Net Carrying Value 378,000 3,000
Weighted-Average Remaining Useful Life (in years) 3 years 3 months 4 days 0 years 2 months 1 day
Core/developed technology
   
Finite-Lived Intangible Assets    
Gross Carrying Value 192,340,000 218,845,000
Accumulated Amortization 175,604,000 173,070,000
Net Carrying Value 16,736,000 45,775,000
Weighted-Average Remaining Useful Life (in years) 0 years 6 months 0 days 1 year 1 month 20 days
Customer relationships
   
Finite-Lived Intangible Assets    
Gross Carrying Value 287,090,000 327,765,000
Accumulated Amortization 263,427,000 264,278,000
Net Carrying Value 23,663,000 63,487,000
Weighted-Average Remaining Useful Life (in years) 0 years 7 months 2 days 1 year 1 month 28 days
Non-compete agreements
   
Finite-Lived Intangible Assets    
Gross Carrying Value 810,000  
Accumulated Amortization 145,000  
Net Carrying Value 665,000  
Weighted-Average Remaining Useful Life (in years) 3 years 3 months 4 days  
In-Process Research and Development
   
Finite-Lived Intangible Assets    
Gross Carrying Value 21,590,000 [2]  
Accumulated Amortization 0 [2]  
Net Carrying Value $ 21,590,000 [2]  
[1] During the nine months ended July 27, 2013, $69.4 million of intangible assets became fully amortized and, therefore, were removed from the balance sheet.
[2] Acquired in-process research and development (“IPRD”) is an intangible asset accounted for as an indefinite-lived asset until the completion or abandonment of the associated research and development effort. While accounted as an indefinite-lived asset, the IPRD intangible asset is subject to testing for impairment annually, as of the first day of the second fiscal quarter, and whenever events or changes in facts and circumstances indicate that it is more likely than not that IPRD is impaired. If the research and development effort associated with the IPRD is successfully completed, then the IPRD intangible asset will be amortized over its estimated useful life to be determined at the date the effort is completed. During the nine months ended July 27, 2013, the IPRD intangible asset was not amortized due to the current stage of the associated research and development effort.